Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

[A case of postmenopausal breast cancer becoming HER2 positive after neoadjuvant hormone therapy].

Inafuku K, Inari H, Goto N, Kawamoto M, Hatori S, Tanabe H, Masuda M.

Gan To Kagaku Ryoho. 2014 Apr;41(4):487-9. Japanese.

PMID:
24743366
2.

[Neoadjuvant endocrine therapy with anastrozole significantly downstaged an elderly breast cancer woman with locally-advanced breast cancer which became operable].

Rai Y, Ando M, Sagara Y, Takahama T, Matsuyama Y, Ooi Y, Sagara Y.

Gan To Kagaku Ryoho. 2005 Sep;32(9):1301-5. Japanese.

PMID:
16184928
3.

[A successful case of a super-elderly breast cancer patient treated with hormone therapy].

Aomatsu N, Kashiwagi S, Asano Y, Morisaki T, Nakamura M, Kawajiri H, Takashima T, Onoda N, Ishikawa T, Hirakawa K.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2042-4. Japanese.

PMID:
23267970
4.

Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial.

Kurosumi M, Takatsuka Y, Watanabe T, Imoto S, Inaji H, Tsuda H, Akiyama F, Sakamoto G, Ikeda T, Noguchi S.

J Cancer Res Clin Oncol. 2008 Jun;134(6):715-22. Epub 2007 Dec 13.

PMID:
18075758
5.

Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.

Smith IE, Dowsett M, Ebbs SR, Dixon JM, Skene A, Blohmer JU, Ashley SE, Francis S, Boeddinghaus I, Walsh G; IMPACT Trialists Group.

J Clin Oncol. 2005 Aug 1;23(22):5108-16. Epub 2005 Jul 5.

PMID:
15998903
6.

[A case of effective trastuzumab plus gemcitabine therapy for human epidermal growth factor receptor 2-positive breast cancer].

Yabe N, Murai S, Shimizu H, Kitasato K, Yoshikawa T, Oto I, Nakadai J, Jinno H, Kitagawa Y.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2396-8. Japanese.

PMID:
24394124
7.

[A case of liver metastasis of breast cancer responding to letrozole].

Hata K, Hirai I, Tanaka T, Tanino H.

Gan To Kagaku Ryoho. 2012 Feb;39(2):257-60. Japanese.

PMID:
22333638
8.

[A Case of Locally Advanced Breast Cancer Treated with Modified Radical Mastectomy with Immediate Reconstruction Using a Tissue Expander after Endocrine Therapy].

Aomatsu N, Tei S, Haraoka G, Hosoi K, Fujii N, Tsujio G, Hiramatsu S, Wang E, Iwauchi T, Morimoto J, Nishii T, Kosaka K, Uchima Y, Takeuchi K.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1812-4. Japanese.

PMID:
26805181
9.

Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists.

Dowsett M, Ebbs SR, Dixon JM, Skene A, Griffith C, Boeddinghaus I, Salter J, Detre S, Hills M, Ashley S, Francis S, Walsh G, Smith IE.

J Clin Oncol. 2005 Apr 10;23(11):2477-92. Epub 2005 Mar 14.

PMID:
15767642
10.

[Two Cases of ER-Positive Postmenopausal Breast Cancer That Increased in Size during Neoadjuvant Hormone Therapy].

Jinno T, Kurumiya Y, Niwa T, Sekoguchi E, Kobayashi S, Kawai K, Kiriyama M.

Gan To Kagaku Ryoho. 2016 Dec;43(13):2539-2542. Japanese.

PMID:
28028261
11.

Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept.

Iwata H.

Breast Cancer. 2011 Apr;18(2):92-7. doi: 10.1007/s12282-010-0233-6. Epub 2010 Dec 8. Review.

PMID:
21140250
12.

[A case of inflammatory breast cancer responding to anastrozole].

Sato T, Nakagawa T, Kuwayama T, Kubota K, Suzuki S, Sugihara K.

Gan To Kagaku Ryoho. 2009 Nov;36(12):2477-9. Japanese.

PMID:
20037461
13.

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.

Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M.

J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. doi: 10.1093/jnci/djn309. Epub 2008 Sep 23.

14.

[Advanced breast cancer in a patient achieving long-term SD after letrozole administration for liver metastasis developing during anastrozole therapy].

Ichinose Y, Kobayashi T, Fujimoto A, Uchida S, Sasaoki T, Goto K.

Gan To Kagaku Ryoho. 2010 Dec;37(13):2913-6. Japanese.

PMID:
21160269
15.

[Three patients with local recurrence of ER-positive breast cancer for whom anastrozole was clinically effective].

Inari H, Hashimoto M, Uesugi K, Goto N, Hatori S, Tanabe H, Iwasaki H.

Gan To Kagaku Ryoho. 2013 Mar;40(3):361-3. Japanese.

PMID:
23507599
16.

[An elderly advanced breast cancer with a good response to anastrozole].

Matsui K, Tazawa K, Karato M, Nagata T, Shimada Y, Tsukada K.

Gan To Kagaku Ryoho. 2010 Aug;37(8):1557-60. Japanese.

PMID:
20716886
17.

[Advanced breast cancer with lung and pleural metastases responsive to anastrozole--a case report].

Sakurai T, Oura S, Kinoshita T, Yokochi H, Enomoto K, Nishimura M, Okamura Y.

Gan To Kagaku Ryoho. 2002 Sep;29(9):1607-10. Japanese.

PMID:
12355946
18.

[A case of stage IV breast cancer with bone metastases that responded well for long-term to hormonal therapy].

Oda G, Nakagawa T, Sato T, Kuwayama T, Yamamoto K, Kawachi H, Kubota K, Sugihara K.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2753-5. Japanese.

PMID:
21224702
19.

Anastrozole as neoadjuvant therapy for patients with hormone-dependent, locally-advanced breast cancer.

Milla-Santos A, Milla L, Calvo N, Portella J, Rallo L, Casanovas JM, Pons M, Rodes J.

Anticancer Res. 2004 Mar-Apr;24(2C):1315-8.

20.

[A case of elderly locally-advanced breast cancer with skin ulcer responding to letrozole].

Sasaki Y, Okuyama M, Hibino M, Tenma K, Nakamura M.

Gan To Kagaku Ryoho. 2012 Jun;39(6):1005-8. Japanese.

PMID:
22705703

Supplemental Content

Support Center